Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA404651
Max Phase: Preclinical
Molecular Formula: C8H11NO4S
Molecular Weight: 217.25
Molecule Type: Small molecule
Associated Items:
ID: ALA404651
Max Phase: Preclinical
Molecular Formula: C8H11NO4S
Molecular Weight: 217.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1nc2c(s1)O[C@H](CO)[C@H](O)[C@@H]2O
Standard InChI: InChI=1S/C8H11NO4S/c1-3-9-5-7(12)6(11)4(2-10)13-8(5)14-3/h4,6-7,10-12H,2H2,1H3/t4-,6+,7-/m1/s1
Standard InChI Key: LAYGJMIHKAUFND-PRMYIZFSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 217.25 | Molecular Weight (Monoisotopic): 217.0409 | AlogP: -0.40 | #Rotatable Bonds: 1 |
Polar Surface Area: 82.81 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.20 | CX Basic pKa: 1.55 | CX LogP: -1.14 | CX LogD: -1.14 |
Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.60 | Np Likeness Score: 0.67 |
1. Amorelli B, Yang C, Rempel B, Withers SG, Knapp S.. (2008) N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines., 18 (9): [PMID:18406613] [10.1016/j.bmcl.2008.03.067] |
Source(1):